Search results for "excision"

showing 10 items of 266 documents

A histological evaluation of the surgical margins from human oral fibrous-epithelial lesions excised with CO2 laser, Diode laser, Er:YAG laser, Nd:YA…

2018

Background We aim to evaluate the presence of histological artefacts in the surgical margins of human oral fibro-epithelial hyperplasias excised with lasers of different wavelengths, and also electrosurgical scalpel and cold scalpel. Moreover, we aim to determine if some of these instruments could impair the normal histological diagnosis of these lesions. Material and Methods We included 130 consecutive surgical samples of 80 females and 50 males (mean age of 53.82±16.55) with a histological diagnosis of an oral benign fibrous-epithelial hyperplasias. The samples were categorized into 6 groups according to the type of instrument used: CO2 laser group, diode laser group, Er:YAG laser group, …

AdultMalePalate HardOral Surgical ProceduresElectrosurgeryLasers Solid-Statelaw.invention03 medical and health sciences0302 clinical medicineTonguelawSurgical removalHistological diagnosisTissue damageMedicineHumansGeneral DentistryAgedRetrospective StudiesMouthCo2 laserHyperplasiabusiness.industryResearchMouth MucosaMargins of ExcisionMean age030206 dentistryMiddle AgedLaser:CIENCIAS MÉDICAS [UNESCO]Surgical Instrumentssurgical procedures operativeOtorhinolaryngologyNd:YAG laserUNESCO::CIENCIAS MÉDICASLasers GasSurgeryFemaleLaser TherapyLasers SemiconductorOral SurgerybusinessNuclear medicineMouth DiseasesEr:YAG laserMedicina oral, patologia oral y cirugia bucal
researchProduct

Metastasectomy With Standardized Lymph Node Dissection for Metastatic Renal Cell Carcinoma: An 11-Year Single-Center Experience

2013

Background Pulmonary metastasectomy (PM) for metastatic renal cell carcinoma is an established method of treatment for selected patients. The incidence of intrathoracic lymph node metastases (ITLNM) and outcomes remain controversial. The purpose of this study was to determine the incidence of ITLNM and long-term outcome of PM for metastatic kidney cancer. Methods From January 1999 to December 2009, 116 patients (82 men, age 61.7 ± 9.0 years) with metastases from kidney cancer underwent PM and systematic lymph node dissection with curative intent. Kaplan-Meier analyses, log-rank test, and Cox regression analyses were used to estimate survival and to determine prognosticators of survival. Res…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentThoracic CavityKaplan-Meier EstimateYoung AdultRenal cell carcinomaGermanymedicineHumansCarcinoma Renal CellLymph nodeAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overUnivariate analysisProportional hazards modelbusiness.industryMortality rateMetastasectomyMiddle Agedmedicine.diseaseKidney NeoplasmsIntrathoracic Lymph NodeSurgerySurvival Ratemedicine.anatomical_structureLymphatic MetastasisLymph Node ExcisionFemaleSurgeryMetastasectomyCardiology and Cardiovascular MedicinebusinessKidney cancerForecastingThe Annals of Thoracic Surgery
researchProduct

Local excision for more advanced rectal tumors

2008

Over the past 20 years, local excision (LE) of T1 rectal cancer was increasingly established and represents an oncologically established technique. In contrast, the situation for T2 tumors is less clear and has only been investigated in small patient collectives. LE for T2 tumors is thus discussed controversially.In addition to our own patients with T2 rectal cancer treated locally (n=40), we have analysed the local recurrence (LR) rates after LE alone (n=124), after immediate conventional radical reoperation (n=29), after adjuvant (chemo)-radiotherapy (n=294) and those after neoadjuvant chemoradiotherapy (nCRT) (n=269) using a PubMed search.LR rates of low-grade T2 tumors after R0 resectio…

AdultMaleReoperationLocal excisionmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentRectal TumorsmedicineAdjuvant therapyHumansRadiology Nuclear Medicine and imagingDigestive System Surgical ProceduresAgedNeoplasm StagingR0 resectionRectal Neoplasmsbusiness.industryCarcinomaHematologyGeneral MedicineMiddle Agedmedicine.diseaseNeoadjuvant TherapySurgeryOncologyChemotherapy AdjuvantFemaleRadiotherapy AdjuvantbusinessAdjuvantFollow-Up StudiesNeoadjuvant chemoradiotherapyActa Oncologica
researchProduct

Local excision of urothelial cancer of the upper urinary tract.

1986

Abstract In 9 of 93 patients (9.7%) with urothelial cancer of the upper tract (7 renal pelvis tumors, 3 ureteral tumors), conservative surgery was employed using a free peritoneal autotransplant for replacement of the renal pelvis in 5 kidneys. Absolute indications for conservative surgery were solitary kidneys/nonfunctioning contralateral kidneys in 4 patients and bilateral tumors in 1 patient. Local recurrences developed 1-3 years after operation in 4 of 6 kidneys (3 patients), 3 of which had grade-2 and grade-3 primary lesions. All patients were treated successfully by repeated local excision. In the presence of a normal contralateral kidney, local tumor excision was done electively in 4…

AdultMaleReoperationLocal excisionmedicine.medical_specialtyUrologyEpitheliumTumor excisionUreterPostoperative ComplicationsmedicineUrothelial cancerHumansKidney PelvisUpper urinary tractAgedUrinary bladderbusiness.industryUreteral NeoplasmsMiddle AgedKidney NeoplasmsSurgerymedicine.anatomical_structureUpper tractFemaleNeoplasm Recurrence LocalPeritoneumbusinessRenal pelvisEuropean urology
researchProduct

Low rectal cancer: abdominoperineal resection or low Hartmann resection? A postoperative outcome analysis.

2011

BACKGROUND In distal rectum cancers, when the sphincters are not affected and it is not possible to perform a coloanal anastomosis because of the presence of comorbidities or the advanced age of the patient, a low Hartmann resection with total mesorectal excision can be performed. Low Hartmann resection is usually considered to be a shorter procedure and to have an inferior morbidity compared with abdominoperineal resection of the rectum. OBJECTIVE This study aimed to compare the postoperative outcome of a series of patients with low rectal cancer who have undergone either low Hartmann resection or abdominoperineal resection. DESIGN This study is a retrospective analysis of data collected i…

AdultMaleReoperationmedicine.medical_specialtyAbdominal AbscessColorectal cancerRectumPatient ReadmissionResectionYoung AdultPostoperative ComplicationsmedicinePostoperative outcomeHumansColoanal anastomosisDigestive System Surgical ProceduresAgedRetrospective StudiesAged 80 and overbusiness.industryAbdominoperineal resectionRectal NeoplasmsGastroenterologyGeneral MedicineMiddle Agedmedicine.diseaseTotal mesorectal excisionSurgerySurvival Ratemedicine.anatomical_structureTreatment OutcomeSphincterFemalebusinessDiseases of the colon and rectum
researchProduct

Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospectiv…

2013

Background To evaluate the correlation between the side of positive biopsy (Bx) and the risk of lymph-node metastases (LNMs) on each side and to quantify the risk of contralateral LNMs in patients with unilateral positive biopsy. Methods We analyzed the outcomes of 1599 patients with complete data regarding the sides of positive Bx and LN (lymph-node). By dividing each prostate into two separate sides, we assessed the accuracy of the side-specific Bx details in determining the side of positive nodes; the area under the receiver-operating characteristic (ROC) (AUCs) was used. For patients with unilateral positive Bx, we assessed the risk of homolateral and contralateral LNMs according to the…

AdultMaleRiskmedicine.medical_specialtyProstate biopsyPelviLymph node metastasis; Pelvic lymph node dissection; Prostate biopsy; Prostate cancer; Radical prostatectomyPelvisProstate biopsyProstate cancerLymph node metastasiProstateBiopsymedicineHumansProspective StudiesProspective surveyAgedAged 80 and overProstatectomyLymph node metastasisProstate cancermedicine.diagnostic_testbusiness.industryNodal metastasisProstatic NeoplasmsLymph NodeLymphatic MetastasiGeneral MedicineMiddle Agedmedicine.diseaseRadical prostatectomySurgeryPelvic lymph node dissectionDissectionProspective Studiemedicine.anatomical_structureROC CurveOncologyLymphatic MetastasisProstatic NeoplasmLymph Node ExcisionSurgeryRadiologyLymph NodesBiopsy Large-Core NeedlebusinessBiopsy findingsHuman
researchProduct

Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.

2003

Aim  The standard treatment for patients with clinically resectable rectal cancer is surgery. Postoperative radiochemotherapy (RCT) is recommended for advanced disease (pT3/4 or pN+). In recent years, encouraging results of pre-operative radiotherapy have been reported. This prospective randomized phase-III-trial (CAO/ARO/AIO-94) compares the efficacy of neoadjuvant RCT to standard postoperative RCT. We report on the design of the study and first results with regard to toxicity of RCT and postoperative morbidity. Patients and methods  Patients with locally advanced operable rectal cancer (uT3/4 or uN+, Mason CS III/IV) were randomly assigned to pre or postoperative RCT: A total dose of 50.4…

AdultMalemedicine.medical_specialtyAntimetabolites AntineoplasticNauseaColorectal cancermedicine.medical_treatment030230 surgerylaw.invention03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRandomized controlled triallawGermanymedicineHumansAgedNeoplasm Stagingbusiness.industryRectal NeoplasmsStandard treatmentPatient SelectionGastroenterologyPostoperative complicationRadiotherapy DosageMiddle Agedmedicine.diseaseTotal mesorectal excisionSurvival AnalysisNeoadjuvant Therapy3. Good healthSurgeryClinical trialRadiation therapyTreatment OutcomeChemotherapy Adjuvant030220 oncology & carcinogenesisQuality of LifeFemaleRadiotherapy AdjuvantFluorouracilmedicine.symptombusinessColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
researchProduct

Developments in esophageal surgery for adenocarcinoma: a comparison of two decades

2007

Abstract Background The objective of this study was to examine outcomes in patients undergoing esophageal resection for adenocarcinoma at our institution during a 20-year period and, in particular, to address temporal trends in long-term survival. Methods Out of 470 patients who underwent esophagectomy for malignancy between September 1985 and September 2005, a total number of 175 patients presented with esophageal adenocarcinoma. Patients enrolled in this study included AEG (adenocarcinoma of the esophagogastric junction) type I tumors only. Time trends were studied comparing two decades, 9/1985 to 9/1995 (DI) and 10/1995 to 9/2005 (DII). Results The overall survival was significantly more…

AdultMalemedicine.medical_specialtyCancer ResearchTime FactorsEsophageal Neoplasmsmedicine.medical_treatmentAdenocarcinomaMalignancylcsh:RC254-282Disease-Free SurvivalSurgical oncologymedicineGeneticsHumansSurvivorsEsophagusSurvival analysisAgedNeoplasm StagingRetrospective Studiesbusiness.industryRetrospective cohort studyMiddle AgedPrognosislcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseCombined Modality TherapySurvival AnalysisSurgeryEsophagectomyLog-rank testTreatment Outcomemedicine.anatomical_structureOncologyEsophagectomyLymph Node ExcisionAdenocarcinomaFemalebusinessResearch ArticleBMC Cancer
researchProduct

Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.

2020

Background Neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer carries a high risk of adverse effects. The aim of this study was to examine the selective application of nCRT based on patient risk profile, as determined by MRI, to find the optimal range between undertreatment and overtreatment. Study Design In this prospective multicenter observational study, nCRT before total mesorectal excision (TME) was indicated in high-risk patients with involved or threatened mesorectal fascia (≤1 mm), or cT4 or cT3 carcinomas of the lower rectal third. All other patients received primary surgery. Results Of the 1,093 patients, 878 (80.3%) were treated according to the protocol, 526 pat…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentMedical OveruseDisease-Free Survival03 medical and health sciences0302 clinical medicinemedicineHumansProspective StudiesStage (cooking)Adverse effectPathologicalAgedNeoplasm StagingAged 80 and overProctectomybusiness.industryRectal NeoplasmsCarcinomaRectumMultimodal therapyChemoradiotherapy AdjuvantMiddle Agedmedicine.diseaseTotal mesorectal excisionMagnetic Resonance ImagingNeoadjuvant TherapySurgeryRadiation therapy030220 oncology & carcinogenesisCase-Control StudiesPractice Guidelines as Topic030211 gastroenterology & hepatologySurgeryFemaleNeoplasm Recurrence LocalbusinessChemoradiotherapyFollow-Up StudiesJournal of the American College of Surgeons
researchProduct

Surgical treatment of primary gastrointestinal stromal tumors (GISTs): Management and prognostic role of R1 resections

2020

Abstract Background Surgery represents the best treatment for primary gastrointestinal stromal tumors (GISTs). The aim of this study is to analyse outcomes of surgical management in order to evaluate the influence of microscopically R1 margins on survival and recurrence in patients affected by GISTs. Methods The study reviewed retrospective data from 74 patients surgically treated for primary GISTs without metastasis at diagnosis. Clinical and pathological findings, surgical procedures, information about follow up and outcomes were analyzed. Results Recurrence rate was low and no patients died in the R1 group during the follow up period. The difference in recurrence free survival for patien…

AdultMalemedicine.medical_specialtyGastrointestinal Stromal TumorsPrognosiMetastasisPositive microscopic margins03 medical and health sciences0302 clinical medicineHumansMedicineIn patientGastrointestinal stromal tumors (GISTs)Surgical treatmentPathologicalGISTsAgedRetrospective StudiesAged 80 and overGiSTbusiness.industryMargins of ExcisionGeneral MedicineMiddle AgedSurgical proceduresPrognosismedicine.diseaseSurgeryLog-rank test030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologySurgeryNeoplasm Recurrence LocalPositive microscopic marginbusinessGISTThe American Journal of Surgery
researchProduct